Literature DB >> 12153544

The neurosteroid allopregnanolone increases dopamine release and dopaminergic response to morphine in the rat nucleus accumbens.

Françoise Rougé-Pont1, Willy Mayo, Michela Marinelli, Mireille Gingras, Michel Le Moal, Pier Vincenzo Piazza.   

Abstract

Neurosteroids are a subclass of steroids that can be synthesized in the central nervous system independently from peripheral sources. Clinical studies in humans have associated these hormones with depression and postpartum mood disorders. In rodents, allopregnanolone (AlloP) has been shown to have anxiolytic and rewarding properties. These observations suggest that neurosteroids could interact with mood and motivation. However, the possible neural substrates of these effects remain unknown. In this report, we have studied the action of AlloP on the activity of the mesencephalic dopaminergic (DA) projection to the nucleus accumbens, which is considered one of the biological substrates of motivation and reward. This study was conducted by measuring extracellular concentrations of dopamine (DA) in the nucleus accumbens by means of microdialysis in freely moving rats. We studied both the direct effect of AlloP and the influence of this hormone on the DA response to an injection of morphine. AlloP dose-dependently increased the release of DA in the nucleus accumbens. Furthermore, this hormone doubled the DA response to morphine. These effects were observed for AlloP doses of 50 and 100 pmol injected intracerebroventricularly. These results suggest that the stimulatory effect of AlloP on DA could mediate some of the behavioural effects of neurosteroids and, in particular, the interaction of these hormones with mood and motivation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12153544     DOI: 10.1046/j.1460-9568.2002.02084.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  32 in total

Review 1.  Progestins influence motivation, reward, conditioning, stress, and/or response to drugs of abuse.

Authors:  Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2006-09-18       Impact factor: 3.533

2.  Cortical 3 alpha-hydroxy-5 alpha-pregnan-20-one levels after acute administration of Delta 9-tetrahydrocannabinol, cocaine and morphine.

Authors:  A Chistina Grobin; Margaret J VanDoren; Linda J Porrino; A Leslie Morrow
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

3.  Overexpression of the steroidogenic enzyme cytochrome P450 side chain cleavage in the ventral tegmental area increases 3α,5α-THP and reduces long-term operant ethanol self-administration.

Authors:  Jason B Cook; David F Werner; Antoniette M Maldonado-Devincci; Maggie N Leonard; Kristen R Fisher; Todd K O'Buckley; Patrizia Porcu; Thomas J McCown; Joyce Besheer; Clyde W Hodge; A Leslie Morrow
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

4.  Ethanol alters local cellular levels of (3α,5α)-3-hydroxypregnan-20-one (3α,5α-THP) independent of the adrenals in subcortical brain regions.

Authors:  Jason B Cook; Stephanie M Nelli; Mackenzie R Neighbors; Danielle H Morrow; Todd K O'Buckley; Antoniette M Maldonado-Devincci; A Leslie Morrow
Journal:  Neuropsychopharmacology       Date:  2014-02-25       Impact factor: 7.853

5.  Allopregnanolone influences the consummatory processes that govern ethanol drinking in C57BL/6J mice.

Authors:  Matthew M Ford; Gregory P Mark; Jeffrey D Nickel; Tamara J Phillips; Deborah A Finn
Journal:  Behav Brain Res       Date:  2007-02-23       Impact factor: 3.332

6.  Neurosteroids in nicotine and morphine dependence.

Authors:  Alessandra Concas; Cristiana Sogliano; Patrizia Porcu; Carla Marra; Andrea Brundu; Giovanni Biggio
Journal:  Psychopharmacology (Berl)       Date:  2005-08-17       Impact factor: 4.530

7.  Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naïve patients with schizophrenia.

Authors:  HuaLin Cai; Xiang Zhou; George G Dougherty; Ravinder D Reddy; Gretchen L Haas; Debra M Montrose; Matcheri Keshavan; Jeffrey K Yao
Journal:  Psychoneuroendocrinology       Date:  2018-02-07       Impact factor: 4.905

8.  Effects of the neuroactive steroid allopregnanolone on intracranial self-stimulation in C57BL/6J mice.

Authors:  A Leslie Morrow; C J Malanga; Eric W Fish; Buddy J Whitman; Jeff F DiBerto; J Elliott Robinson
Journal:  Psychopharmacology (Berl)       Date:  2014-05-09       Impact factor: 4.530

9.  Effects of allopregnanolone on the reinstatement of cocaine-seeking behavior in male and female rats.

Authors:  Justin J Anker; Nathan A Holtz; Natalie Zlebnik; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2008-11-08       Impact factor: 4.530

Review 10.  Allopregnanolone and reproductive psychiatry: an overview.

Authors:  Katherine McEvoy; Lauren M Osborne
Journal:  Int Rev Psychiatry       Date:  2019-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.